Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy

Journal of Hematology and Oncology

Volumn 6, Issue 1, 2013, Pages

  Huang, Limin ^a,b   Perrault, Christelle ^b   Coelho Martins, Jennifer ^b   Hu, Chaoquan ^b   Dulong, Charlène ^a   Varna, Mariana ^b,c   Liu, Jielin ^b,d   Jin, Jian ^b,e   Soria, Claudine ^a,b   Cazin, Lionel ^a   Janin, Anne ^b,c,f   Li, Hong ^a,b   Varin, Rémi ^a   Lu, He ^b,c  

^a UNIVERSITÉ DE ROUEN   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d GUIZHOU MEDICAL UNIVERSITY   (China)

^e JIANGNAN UNIVERSITY   (China)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

Anti cancer therapy; ATP dependent transporter; Drug resistance; Endothelial cells

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; VERAPAMIL; VINBLASTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER CELL; CANCER GRAFT; CANCER GROWTH; CANCER THERAPY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAXIMUM TOLERATED DOSE; MOUSE; MULTIDRUG RESISTANCE; NEOPLASM; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; TUMOR VOLUME; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; NEOPLASMS; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL CELLS; FEMALE; HETEROGRAFTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASMS;

EID: 84880018525     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-6-49     Document Type: Article

References (48)

1. Tumor angiogenesis: therapeutic implications. Folkman J, N Engl J Med 1971 285 1182 1186 10.1056/NEJM197111182852108 4938153
2. Tumor dormancy in vivo by prevention of neovascularization. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J, J Exp Med 1972 136 261 276 10.1084/jem.136.2.261 5043412
3. Role of angiogenesis in tumor growth and metastasis. Folkman J, Semin Oncol 2002 29 15 18 12516034
4. Angiogenesis: an organizing principle for drug discovery? Folkman J, Nat Rev Drug Discov 2007 6 273 286 10.1038/nrd2115 17396134
5. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary andmetastatic disease. Teicher BA, Sotomayor EA, Huang ZD, Cancer Res 1992 52 6702 4 1384969
6. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Kakeji Y, Teicher BA, Invest New Drugs 1997 15 39 48 10.1023/A:1005718628223 9195288
7. Endothelial cell proliferation as a novel approach to targeting tumor therapy. Denekamp J, Br J Cancer 1982 45 136 139 10.1038/bjc.1982.16 7059456
8. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Denekamp J, Br J Radiol 1993 66 181 196 10.1259/0007-1285-66-783-181 7682469
9. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. Kerbel RS, Bioessays 1991 13 31 36 10.1002/bies.950130106 1722975
10. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Biedler JL, Riehm H, Cancer Res 1970 30 1174 1184 5533992
11. Molecular mechanisms of drug resistance in tumours. Harrison DJ, J Pathol 1995 175 7 12 10.1002/path.1711750103 7891229
12. Molecular mechanisms of drug resistance. Longley DB, Johnston PG, J Pathol 2005 205 275 292 10.1002/path.1706 15641020
13. Multidrug resistance in cancer: role of ATP-dependent transporters. Gottesman MM, Fojo T, Bates SE, Nature Rev Cancer 2002 2 48 58 10.1038/nrc706
14. The genetics of ATP-binding cassette transporters. Dean M, Methods Enzymol 2005 400 409 429 16399363
15. Transmembrane transport of endo-and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Deeley RG, Westlake C, Cole SP, Physiol Rev 2006 86 849 899 10.1152/physrev.00035.2005 16816140
16. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Juliano RL, Ling V, Biochem Biophys Acta 1976 455 152 162 10.1016/0005-2736(76)90160-7 990323
17. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR, J Histochem Cytochem 1990 38 1277 1287 10.1177/38.9.1974900 1974900
18. Biochemistry of multidrug resistance mediated by the multidrug transporter. Gottesman MM, Pastan I, Annu Rev Biochem 1993 62 385 427 10.1146/annurev.bi.62.070193.002125 8102521
19. Structure and function of ABC transporters: the ATP switch provides flexible control. Linton KJ, Higgins CF, Pflugers Arch 2007 453 555 567 10.1007/s00424-006-0126-x 16937116
20. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, et al. Proc Natl Acad Sci USA 1989 86 695 698 10.1073/pnas.86.2.695 2563168
21. Modulation of multidrug resistance: a paradigm for translational clinical research. Sikic BI, Oncology (Williston Park) 1999 13 183 7
22. Modulation and prevention of multidrug resistance by inhibitors of P glycoprotein. Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G, Cancer Chemother Pharmacol 1997 40 Suppl 13 19
23. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Allen JD, Brinkhuis RF, van Deemter L, Wijnholds J, Schinkel AH, Cancer Res 2000 60 5761 5766 11059771
24. Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption. Smit JW, Schinkel AH, Muller M, Weert B, Meijer DK, Hepatology 1998 27 1056 1063 10.1002/hep.510270422 9537446
25. The human ATP-binding cassette (ABC) transporter superfamily. Dean M, Rzhetsky A, Allikmets R, Genome Res 2001 11 1156 1166 10.1101/gr.GR-1649R 11435397
26. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, Doxorubicin, and vinblastine. Ueda K, Cardarelli C, Gottesman MM, Pastan I, Proc Natl Acad Sci USA 1987 84 3004 3008 10.1073/pnas.84.9.3004 3472246
27. Multidrug resistance-associated protein subfamily transporters and drug resistance. Kuwano M, Toh S, Uchiumi T, Takano H, Kohno K, Wada M, Anticancer Drug Des 1999 14 123 131 10405639
28. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Xiong YQ, Sun HC, Zhang W, Zhu XD, Zhuang PY, Zhang JB, et al. Clin Cancer Res 2009 15 4838 4846 10.1158/1078-0432.CCR-08-2780 19638466
29. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Natarajan K, Xie Y, Baer MR, Ross DD, Biochem Pharmacol 2012 83 1084 1103 10.1016/j.bcp.2012.01.002 22248732
30. Expression and function of multidrug resistance transporters at the blood-brain barriers. Scherrmann JM, Expert Opin Drug Metab Toxicol 2005 1 233 246 10.1517/17425255.1.2.233 16922639
31. Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. Seetharaman S, Barrand MA, Maskell L, Scheper RJ, J Neurochem 1998 70 1151 1159 9489736
32. In situlocalization of P-glycoprotein (ABCB1) in human and rat brain. Bendayan R, Ronaldson PT, Gingras D, Bendayan M, J Histochem Cytochem 2006 54 1159 1167 10.1369/jhc.5A6870.2006 16801529
33. Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems. Lee G, Babakhanian K, Ramaswamy M, Prat A, Wosik K, Bendayan R, Pharm Res 2007 24 1262 1274 10.1007/s11095-007-9244-1 17380269
34. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Zhang Y, Han H, Elmquist WF, Miller DW, Brain Res 2000 876 148 153 10.1016/S0006-8993(00)02628-7 10973603
35. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Dauchy S, Miller F, Couraud PO, Weaver RJ, Weksler B, Romero IA, Scherrmann JM, De Waziers I, Declèves X, Biochem Pharmacol 2009 77 897 909 10.1016/j.bcp.2008.11.001 19041851
36. Tumour endothelial cells acquire drug resistance in a tumour microenvironment. Hida K, Akiyama K, Ohga N, Maishi N, Hida Y, J Biochem 2013 153 243 249 10.1093/jb/mvs152 23293323
37. Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment. Akiyama K, Ohga N, Hida Y, Kawamoto T, Sadamoto Y, Ishikawa S, Maishi N, Akino T, Kondoh M, Matsuda A, Inoue N, Shindoh M, Hida K, Am J Pathol 2012 180 3 1283 1293 10.1016/j.ajpath.2011.11.029 22245726
38. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Trochon-Joseph V, Martel-Renoir D, Mir LM, Thomaïdis A, Opolon P, Connault E, Li H, Grenet C, Fauvel-Lafève F, Soria J, Legrand C, Soria C, Perricaudet M, Lu H, Cancer Res 2004 64 2062 2069 10.1158/0008-5472.CAN-03-3272 15026344
39. Culture of human endothelial cells derived from umbilical veins. Jaffe E, Nachman R, Becker C, Minick C, J Clin Invest 1973 52 2745 2756 10.1172/JCI107470 4355998
40. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Ji BS, He L, Liu GQ, Life Sci 2005 77 2221 2232 10.1016/j.lfs.2004.12.050 15967469
41. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Schinkel AH, Jonker JW, Adv Drug Deliv Rev 2003 55 23 29
42. Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance. Goler-Baron V, Assaraf YG, PLoS One 2011 6 16007 10.1371/journal.pone.0016007 21283667
43. Drug transporters as targets for cancer chemotherapy. Nakanishi T, Cancer Genomics Proteomics 2007 4 241 254 17878527
44. The therapeutic promise of the cancer stem cell concept. Frank NY, Schatton T, Frank MH, J Clin Invest 2010 120 41 50 10.1172/JCI41004 20051635
45. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Jain RK, Nat Med 2001 7 987 989 10.1038/nm0901-987 11533692
46. Multidrug resistance in cancer. Baguley BC, Methods Mol Biol 2010 596 11 14
47. Use of arrays to investigate the contribution of ATP-binding cassette transporters to drug resistance in cancer chemotherapy and prediction of chemosensitivity. Zhang JT, Cell Res 2007 17 311 323 10.1038/cr.2007.15 17404598
48. Tumor endothelial cells join the resistance. Dudley AC, Klagsbrun M, Clin Cancer Res 2009 15 4787 4789 10.1158/1078-0432.CCR-09-0902 19638456